Introducing the PULS Cardiac Test

Every 37 seconds, someone in the United States dies from cardiovascular disease. For more than 50 years, heart disease has remained the leading cause of death for men, women, and people of most racial and ethnic groups around the world. Around 25% of all deaths in the U.S. and 30% of all deaths worldwide each year are the result of heart disease.

Early detection is the key to lowering these numbers. Unfortunately, heart attacks can be a silent killer with no signs or symptoms before they strike. Over 50% of individuals presenting with a severe cardiac event have normal cholesterol levels, or at most just one risk factor. 

These are troubling statistics for patients, and also for the doctors who work hard to accurately identify those who are at risk of a heart attack.

PULS: A Test That Detects the Leading Cause of Heart Attacks

The PULS Cardiac Test is a simple, non-invasive blood test that predicts the likelihood of a patient having a heart attack within the next five years. It works by detecting the true leading cause of heart attacks: Unstable Cardiac Lesion Ruptures.

The PULS Test (which stands for Protein Unstable Lesion Signature) looks for biomarkers that measure the body’s immune response to arterial injuries. Over time, these injuries lead to the formation of cardiac lesions, which can rupture and trigger cardiac events. Cardiac lesions often progress without any warning signs or symptoms.

The PULS Cardiac Test is extremely accurate at identifying at-risk patients who are commonly missed by other testing modalities, such as cholesterol testing and plaque testing. It can be used for both diagnostic and predictive purposes to broaden the spectrum of patients that are identified and treated with regards to ACS (acute coronary syndrome).

Physicians can order the PULS Cardiac Test for patients 40 years or older who have no previous history of a myocardial infarction, to uncover hidden risks and begin treatment early. The PULS Cardiac Test conforms to all guidelines by the American Heart Association (AHA) and the American College of Cardiology (ACC).

The PULS Test and COVID-19

In the time of COVID-19, this type of testing is more important than ever before. Patients with cardiovascular disease, diabetes, compromised immune systems, and other chronic illnesses are at the highest risk of developing complications from the virus. 

In a study of Chinese patients diagnosed with COVID-19, researchers found that there is a direct link between certain elevated biomarkers and patients who become critically ill from the virus. Specifically, these researchers concluded that detecting MCP-3 expression levels in patients with COVID-19 in the early stage of their illness may help guide treatment strategies. 

The PULS Cardiac Test measures MCP-3 and HGF, two of the biomarkers identified in this research. Not only could this test help save lives by identifying heart attack risk sooner, it could also be used to identify patients with a high COVID-19 risk who require more aggressive treatment plans.

How to Order the PULS Cardiac Test

The PULS Cardiac Test is the starting point for saving lives by identifying at-risk patients sooner. MOMS is proud to feature the PULS Cardiac Test as one of the founding labs on our network. Soon, patients will be able to search for the PULS Cardiac Test in their local areas using the MOMS app.

Are you a patient interested in finding PULS Cardiac Test availability near you? Stay tuned for the release of our app, where you can find and schedule the lab tests you need instantly. Learn more!

Are you a clinical lab interested in promoting your services to the MOMS network and increasing your revenue? Learn more and contact us today.